Compare Glenmark Pharma with GRANULES INDIA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs GRANULES INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA GRANULES INDIA GLENMARK PHARMA/
GRANULES INDIA
 
P/E (TTM) x 13.9 14.4 96.2% View Chart
P/BV x 2.0 3.7 53.8% View Chart
Dividend Yield % 0.5 0.5 107.7%  

Financials

 GLENMARK PHARMA   GRANULES INDIA
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-21
GRANULES INDIA
Mar-21
GLENMARK PHARMA/
GRANULES INDIA
5-Yr Chart
Click to enlarge
High Rs573438 130.8%   
Low Rs195138 141.5%   
Sales per share (Unadj.) Rs387.8130.7 296.7%  
Earnings per share (Unadj.) Rs34.422.2 155.0%  
Cash flow per share (Unadj.) Rs50.128.3 177.0%  
Dividends per share (Unadj.) Rs2.501.50 166.7%  
Avg Dividend yield %0.70.5 125.0%  
Book value per share (Unadj.) Rs249.686.8 287.4%  
Shares outstanding (eoy) m282.17247.67 113.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.02.2 44.9%   
Avg P/E ratio x11.213.0 86.0%  
P/CF ratio (eoy) x7.710.2 75.3%  
Price / Book Value ratio x1.53.3 46.4%  
Dividend payout %7.36.8 107.5%   
Avg Mkt Cap Rs m108,35371,337 151.9%   
No. of employees `000NANA-   
Total wages/salary Rs m23,4373,243 722.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m109,43932,375 338.0%  
Other income Rs m502269 186.8%   
Total revenues Rs m109,94132,644 336.8%   
Gross profit Rs m21,2898,552 248.9%  
Depreciation Rs m4,4361,515 292.8%   
Interest Rs m3,531263 1,343.5%   
Profit before tax Rs m13,8257,044 196.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,1241,549 266.2%   
Profit after tax Rs m9,7015,495 176.6%  
Gross profit margin %19.526.4 73.6%  
Effective tax rate %29.822.0 135.6%   
Net profit margin %8.917.0 52.2%  
BALANCE SHEET DATA
Current assets Rs m73,59619,970 368.5%   
Current liabilities Rs m42,01011,731 358.1%   
Net working cap to sales %28.925.4 113.4%  
Current ratio x1.81.7 102.9%  
Inventory Days Days716 40.7%  
Debtors Days Days86863 9.9%  
Net fixed assets Rs m67,09317,157 391.1%   
Share capital Rs m282248 113.9%   
"Free" reserves Rs m70,14821,262 329.9%   
Net worth Rs m70,43021,510 327.4%   
Long term debt Rs m38,8883,411 1,139.9%   
Total assets Rs m140,68937,127 378.9%  
Interest coverage x4.927.8 17.7%   
Debt to equity ratio x0.60.2 348.1%  
Sales to assets ratio x0.80.9 89.2%   
Return on assets %9.415.5 60.6%  
Return on equity %13.825.5 53.9%  
Return on capital %15.929.3 54.2%  
Exports to sales %081.9 0.0%   
Imports to sales %026.8 0.0%   
Exports (fob) Rs mNA26,528 0.0%   
Imports (cif) Rs mNA8,691 0.0%   
Fx inflow Rs m35,75326,528 134.8%   
Fx outflow Rs m12,0238,691 138.3%   
Net fx Rs m23,72917,837 133.0%   
CASH FLOW
From Operations Rs m11,3124,325 261.6%  
From Investments Rs m-6,752-2,771 243.6%  
From Financial Activity Rs m-4,418-2,993 147.6%  
Net Cashflow Rs m278-1,441 -19.3%  

Share Holding

Indian Promoters % 46.5 41.7 111.5%  
Foreign collaborators % 0.0 0.4 -  
Indian inst/Mut Fund % 41.2 24.0 172.2%  
FIIs % 34.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 53.5 58.0 92.3%  
Shareholders   85,475 239,520 35.7%  
Pledged promoter(s) holding % 0.0 7.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   SAMRAT PHARMA  GENNEX LAB.  KIMIA BIOSCIENCES  TORRENT PHARMA  PHAARMASIA  



Today's Market

Sensex Ends 336 Points Lower, Nifty Falls Below 18,200; Asian Paints Tanks 5%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

GLENMARK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of GLENMARK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY22); Net Profit Up 20.7% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 20.7% YoY). Sales on the other hand came in at Rs 30 bn (up 26.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 132.5% (Quarterly Result Update)

Sep 1, 2020 | Updated on Sep 1, 2020

For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 64.0% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Oct 21, 2021 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - KAMRON LABORATORIES COMPARISON

COMPARE GLENMARK PHARMA WITH

MARKET STATS